A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

Growth hormone deficiency (GHD) is a rare disorder characterized by the insufficient production of growth hormone, which is essential for stimulating the growth of bones and other tissues. Children ...

Barinthus Biotherapeutics is currently working on therapeutics for HPV and celiac disease, two disease areas that are projected to grow rapidly.

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

No drug is free from risks, and no two human anatomies are completely identical (meaning different individuals can face different risks), but from a real-world patient perspective — anecdotally — the ...

“I don’t care where you place me, but just make sure it’s terrifying,” was the last input I gave when my company, Novo Nordisk, was determining my job swap for the next year. So when I first learned ...